BriaCell Therapeutics Corp. (BCTX)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20261 patent granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to BriaCell Therapeutics Corp.’s names, not what it holds today.
3 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jan 24, 2023 | 11,559,574 | Whole-cell cancer vaccines and methods for selection thereof | Pharmaceuticals | BriaCell Therapeutics Corp. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jun 12, 2025 | 2025/0186568 | CANCER VACCINES AND METHODS OF USE THEREOF | Pharmaceuticals | BriaCell Therapeutics Corp. |
| Sep 7, 2023 | 2023/0277640 | WHOLE-CELL CANCER VACCINES AND METHODS FOR SELECTION THEREOF | Pharmaceuticals | BriaCell Therapeutics Corp. |
| Feb 14, 2019 | 2019/0046624 | WHOLE-CELL CANCER VACCINES AND METHODS FOR SELECTION THEREOF | Pharmaceuticals | BriaCell Therapeutics Corp. · patent 11,559,574 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.